Table of Contents
Calming and sleeping stagnated in current retail value terms to remain at ¥4.1 billion in 2014. Stagnation was a result of no new launches and most manufacturers did not invest in promotional activities. The category however, recorded a marginally better performance than 2013’s decline due to the tax hike and the following retail price increase. There has been a negative image of calming and sleeping products. Taking medications regularly to calm down and fall asleep is still considered...
Euromonitor International's Calming and Sleeping in Japan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2010-2014, allowing you to identify the sectors driving growth. Forecasts to 2019 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Calming and Sleeping market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Get Industry Insights. Simply.
Talk to Amrita
+1 718 303 2019
Use this report to: - Receive information concerning the dynamics and forecasts in the OTC drugs and dietary supplements market - Receive information pertaining to the major regional trends in the global ...
The U.S. insomnia market is projected to reach USD 4.24 billion by 2021 from USD 3.38 billion in 2016, growing at a CAGR of 4.6% from 2016 to 2021 In 2016, the cognitive behavioural therapy for insomnia ...
This report provides insight into the current market scenario, structure and practices. In depth market scenario includes: - Current market size estimate - Revenues by players - Top 5 Companies - Market ...